Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger R Reddel

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Nucleic Acids Research|May 3, 2018
Telomere sequence content can be used to determine ALT activity in tumoursMichael Lee, Erdahl T Teber, Oliver Holmes, et al.
Plos Genetics|July 26, 2012
Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathwayCourtney A Lovejoy, Wendi Li, Steven Reisenweber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2026
Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction using three independent cohortsAdel T Aref, Mohashin Pathan, Rosemary Habib, et al.
Nature Communications|August 1, 2020
Strategies to enable large-scale proteomics for reproducible researchRebecca C Poulos, Peter G Hains, Rohan Shah, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2025
Blocking MIF secretion enhances CAR T-cell efficacy against neuroblastomaJosephine G M Strijker, Guillem Pascual-Pasto, Grant P Grothusen, et al.
Life Science Alliance|December 5, 2023
Proteomic-based stratification of intermediate-risk prostate cancer patientsQing Zhong, Rui Sun, Adel T Aref, et al.
Life Science Alliance|December 1, 2025
Correction: Proteomic-based stratification of intermediate-risk prostate cancer patientsQing Zhong, Rui Sun, Adel T Aref, et al.
Cancer Cell|July 15, 2022
Pan-cancer proteomic map of 949 human cell linesEmanuel Gonçalves, Rebecca C Poulos, Zhaoxiang Cai, et al.
Cancer Research Communications|September 26, 2025
Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype StratificationAdel T Aref, Jason Grealey, Mohashin Pathan, et al.
Research Square|July 9, 2024
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profilesAidan Flynn, Andrew D Pattison, Shiva Balachander, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Nucleic Acids Research|May 3, 2018
Telomere sequence content can be used to determine ALT activity in tumoursMichael Lee, Erdahl T Teber, Oliver Holmes, et al.
Plos Genetics|July 26, 2012
Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathwayCourtney A Lovejoy, Wendi Li, Steven Reisenweber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2026
Proteomics-Driven Risk Stratification in Stage III Colon Cancer: A Validated Prognostic Signature for Recurrence Prediction using three independent cohortsAdel T Aref, Mohashin Pathan, Rosemary Habib, et al.
Nature Communications|August 1, 2020
Strategies to enable large-scale proteomics for reproducible researchRebecca C Poulos, Peter G Hains, Rohan Shah, et al.
European Journal of Cancer (Oxford, England : 1990)|February 5, 2025
Blocking MIF secretion enhances CAR T-cell efficacy against neuroblastomaJosephine G M Strijker, Guillem Pascual-Pasto, Grant P Grothusen, et al.
Life Science Alliance|December 5, 2023
Proteomic-based stratification of intermediate-risk prostate cancer patientsQing Zhong, Rui Sun, Adel T Aref, et al.
Life Science Alliance|December 1, 2025
Correction: Proteomic-based stratification of intermediate-risk prostate cancer patientsQing Zhong, Rui Sun, Adel T Aref, et al.
Cancer Cell|July 15, 2022
Pan-cancer proteomic map of 949 human cell linesEmanuel Gonçalves, Rebecca C Poulos, Zhaoxiang Cai, et al.
Cancer Research Communications|September 26, 2025
Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype StratificationAdel T Aref, Jason Grealey, Mohashin Pathan, et al.
Research Square|July 9, 2024
Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profilesAidan Flynn, Andrew D Pattison, Shiva Balachander, et al.
Pageof 15